# EDGAR Filing Document

**Accession Number:** 0001775194
**File Stem:** 0001477932-25-004692
**Filing Date:** 2025-6
**Character Count:** 5809
**Document Hash:** 024e76abadc35e90b1d131159601aa95
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001477932-25-004692.hdr.sgml**: 20250620

**ACCESSION NUMBER**: 0001477932-25-004692

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250616

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250620

**DATE AS OF CHANGE**: 20250620

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** UPEXI, INC.
- **CENTRAL INDEX KEY:** 0001775194
- **STANDARD INDUSTRIAL CLASSIFICATION:** MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 833378978
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-40535
- **FILM NUMBER:** 251058930

**BUSINESS ADDRESS:**
- **STREET 1:** 3030 ROCKY POINT DRIVE
- **STREET 2:** SUITE 420
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607
- **BUSINESS PHONE:** 701-353-5425

**MAIL ADDRESS:**
- **STREET 1:** 3030 ROCKY POINT DRIVE
- **STREET 2:** SUITE 420
- **CITY:** TAMPA
- **STATE:** FL
- **ZIP:** 33607

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** GROVE, INC.
- **DATE OF NAME CHANGE:** 20190429

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**Pursuant to Section 13 or 15(d) of**

**the Securities Exchange Act of 1934**

**Date of report (Date of earliest event reported): June 16, 2025**

---

| |
|:---|
| **UPEXI, INC.** |
| (Exact name of registrant as specified in its charter) |

---

---

| | | |
|:---|:---|:---|
| **Nevada** | **333-25526** | **83-3378978** |
| (State or other jurisdiction<br> of incorporation) | (Commission<br> File Number) | (I.R.S. Employer <br> Identification Number) |

---

---

| |
|:---|
| **3030 N. Rocky Point Drive, Suite 420**<br> **<u>Tampa, FL 33607</u>** |
| (Address of principal executive offices) |

---

---

| |
|:---|
| **<u>(701) 353-5425</u>** |
| (Registrant's telephone number, including area code) |

---

(Former name or former address, if changed since last report)<br>

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions.

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

**Item 5.07 Submission of Matters to a Vote of Security Holders.**

On June 16, 2025, Upexi, Inc. (the "Company") (NASDAQ: UPXI) held its 2025 Annual Meeting of stockholders. The following matters were considered:

**1. Election of Directors** 

Stockholders elected all of the Company's nominees for director for one-year terms expiring on the next annual meeting of stockholders. The voting results were as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  |  | **For** | **Against** | **Withheld**  |
| (1) | Mr. Allan Marshall | 1800047 | – | 54498 |
| (2) | Mr. Andrew Norstrud | 1832266 | – | 22279 |
| (3) | Mr. Gene Salkind | 1817737 | – | 36808 |
| (4) | Mr. Thomas Williams | 1816800 | – | 37745 |
| (5) | Mr. Lawrence Dugan | 1817625 | – | 36920 |

---

**2. Approve Re-Domiciling of the Company as a Delaware Corporation**

Stockholders approved the re-domiciling of the Company as a Delaware Corporation. The voting results were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstained/Withheld** | **Broker Non-Vote** |
| 1,835,223 | 2,150 | 17,172 | 301,423 |

---

**3. Increase in Number of Shares to Stock Option Plan**

Stockholders approved an increase in the number of shares to the Company's Stock Option Plan to 10,000,000 shares. The voting results were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstained/Withheld** | **Broker Non-Vote** |
| 1,780,880 | 73,501 | 164 | 301,423 |

---

**4. Advisory Vote on Executive Compensation**

Stockholders approved the advisory vote on the compensation of the Company's named executive officers. The voting results were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstained/Withheld** | **Broker Non-Vote** |
| 1,784,871 | 69,408 | 266 | 301,423 |

---

**5. Advisory Vote on Frequency of Advisory Vote on Executive Compensation**

Stockholders approved, on a non-binding, advisory basis, the frequency of 3 years for future advisory votes on the compensation of the Company's named executive officers. The voting results were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **1 Year** | **2 Years** | **3 Years** | **Abstain** |
| 191,206 | 1,425 | 1,659,927 | 1,987 |

---

**6. Ratify GBQ Partners LLC as Independent Registered Public Accountant** 

Stockholders approved and ratified the appointment of GBQ Partners LLC to serve as the Company's independent registered public accounting firm for the fiscal year 2025. The voting results were as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstained/Withheld** | **Broker Non-Vote** |
| 2,109,084 | 45,622 | 1,262 | - |

---

**SIGNATURES**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | **UPEXI, INC.** | **UPEXI, INC.** |
| Date: June 19, 2025 | By:  | */s/ Andrew Norstrud* |
|  |  | Andrew Norstrud |
|  |  | Chief Financial Officer |

---